transcriptions 相關
廣告- TransfectionSelect Tool
Recommends products & protocols
Choose solution quickly & wisely
- Gene Editing Resource
Complete cell engineering guidebook
Optimized, validated technologies
- CTS Learning Center
Maximize your time, effort, and
outcomes with these resources.
- Buy mMESSAGE mMACHINE T7
mRNA Kit with CleanCap Reagent AG
Increased translatability in vivo
- Gene Editing Tools
Trusted solutions for gene editing
Optimized and validated protocols
- Media and Reagents
Seamlessly transition your research
to the clinic with CTS products.
- TransfectionSelect Tool
搜尋結果
亞諾法奈米抗體等三大主軸產品並進,下半年可望逐步發酵
財訊快報· 4 天前【財訊快報/記者何美如報導】亞諾法(4133)第一季費用控管得宜,業外又有匯兌利益進補,稅後淨利年增149%,每股盈餘0.44元。亞諾法表示,今年營運將以 ...
亞諾法續布局高端市場,力拚下半年逐步發酵-MoneyDJ理財網
MoneyDJ理財網· 3 天前RNAFLEX RNA IVT自動化機台方面,公司則表示,新冠疫情帶動mRNA疫苗迅速發展,RNA IVT(in vitro transcription)技術隨之廣泛應用於癌症、罕見疾病、慢性病 ...
transcriptions 相關
廣告